Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage
- 1 October 1993
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 9 (3) , 189-217
- https://doi.org/10.1002/dmr.5610090304
Abstract
No abstract availableThis publication has 113 references indexed in Scilit:
- RetractionBiochemical and Biophysical Research Communications, 1991
- Expression of P30, a protein with adhesive properties, in Schwann cells and neurons of the developing and regenerating peripheral nerve.The Journal of cell biology, 1991
- Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 1989
- Essential fatty acids prevent slowed nerve conduction in streptozotocin diabetic ratsJournal of Diabetic Complications, 1988
- A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic ratsBiochemical and Biophysical Research Communications, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Nerve growth factor as a paradigm for other polypeptide growth factorsTrends in Neurosciences, 1986
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Sorbitol, inositol and nerve conduction in diabetesLife Sciences, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983